Affecting one in 36,000 people, von Hippel-Lindau (VHL) is caused by a mutation in the VHL gene and causes tumors to grow in certain parts of the body, including the brain, spinal cord ...
While some control of gene expression is mediated through ... for binding with another cellular protein called the von Hippel-Lindau tumor suppressor (pVHL). The pVHL is a protein involved in ...
In addition, we have created a knockout for the von Hippel Lindau disease (VHL) gene and are interested in modeling VHL deficient cancers in zebrafish. The zebrafish provides a powerful organism to ...
Approximately three-quarters of renal cancers are clear-cell carcinomas, and most tumors of this histologic subtype have inactivating mutations of the von Hippel–Lindau gene. This inactivation ...
Clinical manifestations in the patient or other family members might also signal a particular disease-causing gene (e.g. a VHL gene mutation suggested by findings of subtle retinal vascular lesions).